176
|
Ackermann M, Ajello M, Albert A, Allafort A, Baldini L, Barbiellini G, Bastieri D, Bechtol K, Bellazzini R, Blandford RD, Bloom ED, Bonamente E, Bottacini E, Bouvier A, Brandt TJ, Brigida M, Bruel P, Buehler R, Buson S, Caliandro GA, Cameron RA, Caraveo PA, Cecchi C, Charles E, Chaves RCG, Chekhtman A, Chiang J, Chiaro G, Ciprini S, Claus R, Cohen-Tanugi J, Conrad J, Cutini S, Dalton M, D'Ammando F, de Angelis A, de Palma F, Dermer CD, Digel SW, Di Venere L, do Couto e Silva E, Drell PS, Drlica-Wagner A, Favuzzi C, Fegan SJ, Ferrara EC, Focke WB, Franckowiak A, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Germani S, Giglietto N, Giordano F, Giroletti M, Glanzman T, Godfrey G, Gomez-Vargas GA, Grenier IA, Grove JE, Guiriec S, Gustafsson M, Hadasch D, Hanabata Y, Harding AK, Hayashida M, Hayashi K, Hewitt JW, Horan D, Hou X, Hughes RE, Inoue Y, Jackson MS, Jogler T, Jóhannesson G, Johnson AS, Kamae T, Kawano T, Knödlseder J, Kuss M, Lande J, Larsson S, Latronico L, Longo F, Loparco F, Lovellette MN, Lubrano P, Mayer M, Mazziotta MN, McEnery JE, Mehault J, Michelson PF, Mitthumsiri W, Mizuno T, Moiseev AA, Monte C, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Nemmen R, Nuss E, Ohsugi T, Okumura A, Orienti M, Orlando E, Ormes JF, Paneque D, Panetta JH, Perkins JS, Pesce-Rollins M, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Razzano M, Razzaque S, Reimer A, Reimer O, Ritz S, Roth M, Schaal M, Schulz A, Sgrò C, Siskind EJ, Spandre G, Spinelli P, Strong AW, Takahashi H, Takeuchi Y, Thayer JG, Thayer JB, Thompson DJ, Tibaldo L, Tinivella M, Torres DF, Tosti G, Troja E, Tronconi V, Usher TL, Vandenbroucke J, Vasileiou V, Vianello G, Vitale V, Werner M, Winer BL, Wood KS, Wood M, Yang Z. Inferred cosmic-ray spectrum from Fermi large area telescope γ-ray observations of Earth's limb. PHYSICAL REVIEW LETTERS 2014; 112:151103. [PMID: 24785023 DOI: 10.1103/physrevlett.112.151103] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/13/2013] [Indexed: 06/03/2023]
Abstract
Recent accurate measurements of cosmic-ray (CR) species by ATIC-2, CREAM, and PAMELA reveal an unexpected hardening in the proton and He spectra above a few hundred GeV, a gradual softening of the spectra just below a few hundred GeV, and a harder spectrum of He compared to that of protons. These newly discovered features may offer a clue to the origin of high-energy CRs. We use the Fermi Large Area Telescope observations of the γ-ray emission from Earth's limb for an indirect measurement of the local spectrum of CR protons in the energy range ∼90 GeV-6 TeV (derived from a photon energy range 15 GeV-1 TeV). Our analysis shows that single power law and broken power law spectra fit the data equally well and yield a proton spectrum with index 2.68±0.04 and 2.61±0.08 above ∼200 GeV, respectively.
Collapse
|
177
|
Barbiellini G, Bastieri D, Bechtol K, Bellazzini R, Blandford RD, Borgland AW, Bregeon J, Bruel P, Buehler R, Buson S, Caliandro GA, Cameron RA, Caraveo PA, Cavazzuti E, Cecchi C, Chaves RCG, Chekhtman A, Cheung CC, Chiang J, Ciprini S, Claus R, Cohen-Tanugi J, D'Ammando F, de Angelis A, Dermer CD, Digel SW, do Couto E Silva E, Drell PS, Drlica-Wagner A, Favuzzi C, Focke WB, Franckowiak A, Fukazawa Y, Fusco P, Gargano F, Gasparrini D, Germani S, Giglietto N, Giommi P, Giordano F, Giroletti M, Glanzman T, Godfrey G, Grenier IA, Grove JE, Guiriec S, Hadasch D, Hayashida M, Hays E, Hughes RE, Jackson MS, Jogler T, Knödlseder J, Kuss M, Lande J, Larsson S, Longo F, Loparco F, Lovellette MN, Lubrano P, Mazziotta MN, Mehault J, Michelson PF, Mizuno T, Moiseev AA, Monte C, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Nemmen R, Nuss E, Ohsugi T, Omodei N, Orienti M, Orlando E, Paneque D, Perkins JS, Piron F, Pivato G, Prokhorov D, Rainò S, Razzano M, Razzaque S, Reimer A, Reimer O, Ritz S, Romoli C, Sánchez-Conde M, Sanchez DA, Sgrò C, Siskind EJ, Spandre G, Spinelli P, Takahashi H, Tanaka T, Tibaldo L, Tinivella M, Tosti G, Troja E, Usher TL, Vandenbroucke J, Vasileiou V, Vianello G, Vitale V, Waite AP, Winer BL, Wood KS, Yang Z. Fermi LARGE AREA TELESCOPE OBSERVATIONS OF BLAZAR 3C 279 OCCULTATIONS BY THE SUN. THE ASTROPHYSICAL JOURNAL 2014; 784:118. [PMID: 34646038 PMCID: PMC8506895 DOI: 10.1088/0004-637x/784/2/118] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Observations of occultations of bright γ-ray sources by the Sun may reveal predicted pair halos around blazars and/or new physics, such as, e.g., hypothetical light dark matter particles-axions. We use Fermi Gamma-Ray Space Telescope (Fermi) data to analyze four occultations of blazar 3C 279 by the Sun on October 8 each year from 2008 to 2011. A combined analysis of the observations of these occultations allows a point-like source at the position of 3C 279 to be detected with significance of ≈3σ, but does not reveal any significant excess over the flux expected from the quiescent Sun. The likelihood ratio test rules out complete transparency of the Sun to the blazar γ-ray emission at a 3σ confidence level.
Collapse
|
178
|
Ackermann M, Ajello M, Asano K, Atwood WB, Axelsson M, Baldini L, Ballet J, Barbiellini G, Baring MG, Bastieri D, Bechtol K, Bellazzini R, Bissaldi E, Bonamente E, Bregeon J, Brigida M, Bruel P, Buehler R, Burgess JM, Buson S, Caliandro GA, Cameron RA, Caraveo PA, Cecchi C, Chaplin V, Charles E, Chekhtman A, Cheung CC, Chiang J, Chiaro G, Ciprini S, Claus R, Cleveland W, Cohen-Tanugi J, Collazzi A, Cominsky LR, Connaughton V, Conrad J, Cutini S, D’Ammando F, de Angelis A, DeKlotz M, de Palma F, Dermer CD, Desiante R, Diekmann A, Di Venere L, Drell PS, Drlica-Wagner A, Favuzzi C, Fegan SJ, Ferrara EC, Finke J, Fitzpatrick G, Focke WB, Franckowiak A, Fukazawa Y, Funk S, Fusco P, Gargano F, Gehrels N, Germani S, Gibby M, Giglietto N, Giles M, Giordano F, Giroletti M, Godfrey G, Granot J, Grenier IA, Grove JE, Gruber D, Guiriec S, Hadasch D, Hanabata Y, Harding AK, Hayashida M, Hays E, Horan D, Hughes RE, Inoue Y, Jogler T, Jóhannesson G, Johnson WN, Kawano T, Knödlseder J, Kocevski D, Kuss M, Lande J, Larsson S, Latronico L, Longo F, Loparco F, Lovellette MN, Lubrano P, Mayer M, Mazziotta MN, McEnery JE, Michelson PF, Mizuno T, Moiseev AA, Monzani ME, Moretti E, Morselli A, Moskalenko IV, Murgia S, Nemmen R, Nuss E, Ohno M, Ohsugi T, Okumura A, Omodei N, Orienti M, Paneque D, Pelassa V, Perkins JS, Pesce-Rollins M, Petrosian V, Piron F, Pivato G, Porter TA, Racusin JL, Rainò S, Rando R, Razzano M, Razzaque S, Reimer A, Reimer O, Ritz S, Roth M, Ryde F, Sartori A, Parkinson PMS, Scargle JD, Schulz A, Sgrò C, Siskind EJ, Sonbas E, Spandre G, Spinelli P, Tajima H, Takahashi H, Thayer JG, Thayer JB, Thompson DJ, Tibaldo L, Tinivella M, Torres DF, Tosti G, Troja E, Usher TL, Vandenbroucke J, Vasileiou V, Vianello G, Vitale V, Winer BL, Wood KS, Yamazaki R, Younes G, Yu HF, Zhu SJ, Bhat PN, Briggs MS, Byrne D, Foley S, Goldstein A, Jenke P, Kippen RM, Kouveliotou C, McBreen S, Meegan C, Paciesas WS, Preece R, Rau A, Tierney D, van der Horst AJ, von Kienlin A, Wilson-Hodge C, Xiong S, Cusumano G, La Parola V, Cummings JR. Fermi-LAT Observations of the Gamma-Ray Burst GRB 130427A. Science 2014; 343:42-7. [DOI: 10.1126/science.1242353] [Citation(s) in RCA: 176] [Impact Index Per Article: 17.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
179
|
Preece R, Burgess JM, von Kienlin A, Bhat PN, Briggs MS, Byrne D, Chaplin V, Cleveland W, Collazzi AC, Connaughton V, Diekmann A, Fitzpatrick G, Foley S, Gibby M, Giles M, Goldstein A, Greiner J, Gruber D, Jenke P, Kippen RM, Kouveliotou C, McBreen S, Meegan C, Paciesas WS, Pelassa V, Tierney D, van der Horst AJ, Wilson-Hodge C, Xiong S, Younes G, Yu HF, Ackermann M, Ajello M, Axelsson M, Baldini L, Barbiellini G, Baring MG, Bastieri D, Bellazzini R, Bissaldi E, Bonamente E, Bregeon J, Brigida M, Bruel P, Buehler R, Buson S, Caliandro GA, Cameron RA, Caraveo PA, Cecchi C, Charles E, Chekhtman A, Chiang J, Chiaro G, Ciprini S, Claus R, Cohen-Tanugi J, Cominsky LR, Conrad J, D'Ammando F, de Angelis A, de Palma F, Dermer CD, Desiante R, Digel SW, Di Venere L, Drell PS, Drlica-Wagner A, Favuzzi C, Franckowiak A, Fukazawa Y, Fusco P, Gargano F, Gehrels N, Germani S, Giglietto N, Giordano F, Giroletti M, Godfrey G, Granot J, Grenier IA, Guiriec S, Hadasch D, Hanabata Y, Harding AK, Hayashida M, Iyyani S, Jogler T, Jóhannesson G, Kawano T, Knödlseder J, Kocevski D, Kuss M, Lande J, Larsson J, Larsson S, Latronico L, Longo F, Loparco F, Lovellette MN, Lubrano P, Mayer M, Mazziotta MN, Michelson PF, Mizuno T, Monzani ME, Moretti E, Morselli A, Murgia S, Nemmen R, Nuss E, Nymark T, Ohno M, Ohsugi T, Okumura A, Omodei N, Orienti M, Paneque D, Perkins JS, Pesce-Rollins M, Piron F, Pivato G, Porter TA, Racusin JL, Rainò S, Rando R, Razzano M, Razzaque S, Reimer A, Reimer O, Ritz S, Roth M, Ryde F, Sartori A, Scargle JD, Schulz A, Sgrò C, Siskind EJ, Spandre G, Spinelli P, Suson DJ, Tajima H, Takahashi H, Thayer JG, Thayer JB, Tibaldo L, Tinivella M, Torres DF, Tosti G, Troja E, Usher TL, Vandenbroucke J, Vasileiou V, Vianello G, Vitale V, Werner M, Winer BL, Wood KS, Zhu S. The First Pulse of the Extremely Bright GRB 130427A: A Test Lab for Synchrotron Shocks. Science 2014; 343:51-4. [DOI: 10.1126/science.1242302] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
180
|
Fraioli F, Anzidei M, Serra G, Liberali S, Fiorelli A, Zaccagna F, Longo F, Anile M, Catalano C. Whole-tumour CT-perfusion of unresectable lung cancer for the monitoring of anti-angiogenetic chemotherapy effects. Br J Radiol 2013; 86:20120174. [PMID: 23908346 DOI: 10.1259/bjr.20120174] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
OBJECTIVE To determine whether CT-perfusion (CT-p) can be used to evaluate the effects of chemotherapy and anti-angiogenic treatment in patients with non-small-cell lung carcinoma (NSCLC) and whether CT-p and standard therapeutic response assessment (RECIST) data obtained before and after therapy correlate. METHODS 55 patients with unresectable NSCLC underwent CT-p before the beginning of therapy and 50 of them repeated CT-p 90 days after it. Therapeutic protocol included platinum-based doublets plus bevacizumab for non-squamous carcinoma and platinum-based doublets for squamous carcinoma. RECIST measurements and calculations of blood flow (BF), blood volume (BV), time to peak (TTP) and permeability surface (PS) were performed, and baseline and post-treatment measurements were tested for statistically significant differences. Baseline and follow-up perfusion parameters were also compared based on histopathological subclassification (2004 World Health Organization Classification of Tumours) and therapy response assessed by RECIST. RESULTS Tumour histology was consistent with large cell carcinoma in 14/50 (28%) cases, adenocarcinoma in 22/50 (44%) cases and squamous cell carcinoma in the remaining 14/50 (28%) cases. BF and PS differences for all tumours between baseline and post-therapy measurements were significant (p=0.001); no significant changes were found for BV (p=0.3) and TTP (p=0.1). The highest increase of BV was demonstrated in adenocarcinoma (5.2±34.1%), whereas the highest increase of TTP was shown in large cell carcinoma (6.9±22.4%), and the highest decrease of PS was shown in squamous cell carcinoma (-21.5±18.5%). A significant difference between the three histological subtypes was demonstrated only for BV (p<0.007). On the basis of RECIST criteria, 8 (16%) patients were classified as partial response (PR), 2 (4%) as progressive disease (PD) and the remaining 40 (80%) as stable disease (SD). Among PR, a decrease of both BF (18±9.6%) and BV (12.6±9.2%) were observed; TTP increased in 3 (37.5%) cases, and PS decreased in 6 (75%) cases. SD patients showed an increase of BF, BV, TTP and PS in 6 (15%), 21 (52.5%), 23 (57.5%) and 2 (5%) cases, respectively. PD patients demonstrated an increase of BF (26±0.2%), BV (2.7±0.1%) and TTP (3.1±0.8%) while only PS decreased (23±0.2%). CONCLUSION CT-p can adequately evaluate therapy-induced alterations in NSCLC, and perfusion parameters correlate with therapy response assessment performed with RECIST criteria. ADVANCES IN KNOWLEDGE Evaluating perfusional parameters, CT-p can demonstrate therapy-induced changes in patients with different types of lung cancer and identify response to treatment with excellent agreement to RECIST measurements.
Collapse
|
181
|
Di Seri M, De Sanctis R, Quadrini S, Adua D, Stumbo L, Del Signore E, Gori B, Grassi P, Basile M, Longo F. Safety and Efficacy of Oral Vinorelbine and Capecitabine Combination for Metastatic Breast Cancer. J Chemother 2013; 23:110-3. [DOI: 10.1179/joc.2011.23.2.110] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
182
|
Grande E, Capdevila J, Díez JJ, Longo F, Carrato A. A significant response to sunitinib in a patient with anaplastic thyroid carcinoma. JOURNAL OF RESEARCH IN MEDICAL SCIENCES : THE OFFICIAL JOURNAL OF ISFAHAN UNIVERSITY OF MEDICAL SCIENCES 2013; 18:623-5. [PMID: 24516498 PMCID: PMC3897033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/22/2012] [Revised: 12/02/2012] [Accepted: 01/06/2013] [Indexed: 11/08/2022]
Abstract
Anaplastic thyroid cancer (ATC) is a rare disease with an incidence of less than three cases per million of habitants in western countries. ATC accounts for 1-10% of all tumors derived from the thyroid gland. Classic chemotherapy approach based on platinum and anthracyclines regimens have been considered standard for the last decades. Novel multitarget agents have shown promising responses; however, no positive randomized clinical trials are available up to now. To our knowledge, the case we are presenting here is the first reported case showing clinical and visual activity using sunitinib as a salvage treatment in an ATC patient who was not fit to receive systemic chemotherapy treatment.
Collapse
|
183
|
Gazzaniga P, Raimondi C, Gradilone A, Biondi Zoccai G, Nicolazzo C, Gandini O, Longo F, Tomao S, Lo Russo G, Seminara P, Vincenzi B, Chimenti I, Cristofanilli M, Frati L, Cortesi E. Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff? J Cancer Res Clin Oncol 2013; 139:1411-6. [PMID: 23736274 DOI: 10.1007/s00432-013-1450-0] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2013] [Accepted: 05/17/2013] [Indexed: 02/05/2023]
Abstract
PURPOSE To assess the prognostic and predictive value of circulating tumor cells (CTCs) in metastatic colorectal cancer (mCRC) irrespective of detection level. MATERIALS AND METHODS We evaluated the prognostic and predictive significance of CTC count at baseline and under treatment in 119 mCRC subjects and compared the standard cutoff (≥3 CTCs/7.5 mL to ≥1 CTCs/7.5 mL). RESULTS An overall comparison was made between patients with 0, 1-2 and ≥3 CTC (median PFS 8, 4 and 5 months, respectively). Two poor prognostic groups were found, including patients with ≥1 CTCs before and during treatment and patients with 0 CTC at baseline who converted to ≥1 CTCs (p = 0.014). CONCLUSIONS The presence of at least 1 CTC at baseline count is predictive for poor prognosis in mCRC patients. Patients with 1-2 CTC should be switched from the favorable prognostic group--conventionally defined by the presence of <3 CTC--to the unfavorable, deserving a more careful monitoring.
Collapse
|
184
|
Caroli M, Mele RM, Tomaselli MA, Cammisa M, Longo F, Attolini E. Response to Mrs. Rapley's comments. Nutr Metab Cardiovasc Dis 2013; 23:e22. [PMID: 23557876 DOI: 10.1016/j.numecd.2012.12.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/11/2012] [Accepted: 12/13/2012] [Indexed: 12/01/2022]
|
185
|
Olmedo E, Earl J, Guerrero C, Longo F, Alcalde R, Soria A, Grande E, Plana N, Carrato A, Garrido P. 41P IS THERE ANY ROLE FOR CIRCULATING TUMOR CELLS IN PATIENTS WITH SMALL CELL LUNG CANCER (SCLC)? Lung Cancer 2013. [DOI: 10.1016/s0169-5002(13)70262-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
186
|
Vañó-Galván S, Longo F, Grillo E, Jaén P. [Panitumumab-induced trichomegaly]. Med Clin (Barc) 2013; 140:e15. [PMID: 23490492 DOI: 10.1016/j.medcli.2013.01.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2012] [Accepted: 01/10/2013] [Indexed: 11/18/2022]
|
187
|
Gamucci T, Vaccaro A, Ciancola F, Pizzuti L, Sperduti I, Moscetti L, Longo F, Fabbri MA, Giampaolo MA, Mentuccia L, Di Lauro L, Vici P. Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis. J Cancer Res Clin Oncol 2013; 139:853-60. [PMID: 23411686 PMCID: PMC3625404 DOI: 10.1007/s00432-013-1388-2] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2012] [Accepted: 01/29/2013] [Indexed: 01/03/2023]
Abstract
PURPOSE Recurrences and deaths are known to occur, even if less frequently, in small, node-negative breast cancer patients, and decision on adjuvant treatments remains controversial. In the present analysis, we evaluate recurrence risk in patients with pT1 a, b, c, node-negative, breast cancer, accordingly with some prognostic biological factors. METHODS We retrospectively evaluated 900 node-negative patients (pT1a, b, c) surgery treated between 2000 and 2009 in four Italian oncologic centers. We defined 3 different cohorts: ER positive (ER+); Her-2 positive (Her-2+); and triple negative (TN). RESULTS pT1a was seen in 7.6% of patients, 37.7 % pT1b, 54.8 % pT1c. Concerning the 3 different cohorts, 58.2 % were ER+; 10.8 % were Her-2+; 8.2 % were TN. Overall, chemotherapy was given to 3.0 %, 27.2 %, 69.8 % of pT1a, b, c, respectively, and to 22.7 %, 58.8 %, 68.9 % of ER+, Her-2+, TN subgroups. At a median follow-up of 67 months, 5-year DFS was 96.3 %, 89.2 %, 89.4 % in pT1a, b, c, respectively (100 %, 93.6 %, 89.8 % in ER+; 100 %, 78.7 %, 85.0 % in Her-2+; 100 %, 76.8 %, 85.2 % in TN) (p = ns). At multivariate analysis, histologic grade and Ki-67 resulted independent prognostic factors. Overall, 5-year OS was 98 %, without differences among pT1a, b, c, or among the 3 cohorts. CONCLUSIONS Overall, 5-year DFS was very favorable in this series of small, node-negative breast cancers, but Her-2+ and TN cohorts have a higher recurrence rate than ER+ cohort (p < 0.0001); pT1c, but also pT1b, in Her-2+ and TN subgroups, have a worse outcome, and effective chemotherapy treatment should be considered in these unfavorable subgroups.
Collapse
|
188
|
Ackermann M, Ajello M, Allafort A, Baldini L, Ballet J, Barbiellini G, Baring MG, Bastieri D, Bechtol K, Bellazzini R, Blandford RD, Bloom ED, Bonamente E, Borgland AW, Bottacini E, Brandt TJ, Bregeon J, Brigida M, Bruel P, Buehler R, Busetto G, Buson S, Caliandro GA, Cameron RA, Caraveo PA, Casandjian JM, Cecchi C, Celik O, Charles E, Chaty S, Chaves RCG, Chekhtman A, Cheung CC, Chiang J, Chiaro G, Cillis AN, Ciprini S, Claus R, Cohen-Tanugi J, Cominsky LR, Conrad J, Corbel S, Cutini S, D'Ammando F, de Angelis A, de Palma F, Dermer CD, do Couto e Silva E, Drell PS, Drlica-Wagner A, Falletti L, Favuzzi C, Ferrara EC, Franckowiak A, Fukazawa Y, Funk S, Fusco P, Gargano F, Germani S, Giglietto N, Giommi P, Giordano F, Giroletti M, Glanzman T, Godfrey G, Grenier IA, Grondin MH, Grove JE, Guiriec S, Hadasch D, Hanabata Y, Harding AK, Hayashida M, Hayashi K, Hays E, Hewitt JW, Hill AB, Hughes RE, Jackson MS, Jogler T, Johannesson G, Johnson AS, Kamae T, Kataoka J, Katsuta J, Knodlseder J, Kuss M, Lande J, Larsson S, Latronico L, Lemoine-Goumard M, Longo F, Loparco F, Lovellette MN, Lubrano P, Madejski GM, Massaro F, Mayer M, Mazziotta MN, McEnery JE, Mehault J, Michelson PF, Mignani RP, Mitthumsiri W, Mizuno T, Moiseev AA, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Nakamori T, Nemmen R, Nuss E, Ohno M, Ohsugi T, Omodei N, Orienti M, Orlando E, Ormes JF, Paneque D, Perkins JS, Pesce-Rollins M, Piron F, Pivato G, Raino S, Rando R, Razzano M, Razzaque S, Reimer A, Reimer O, Ritz S, Romoli C, Sanchez-Conde M, Schulz A, Sgro C, Simeon PE, Siskind EJ, Smith DA, Spandre G, Spinelli P, Stecker FW, Strong AW, Suson DJ, Tajima H, Takahashi H, Takahashi T, Tanaka T, Thayer JG, Thayer JB, Thompson DJ, Thorsett SE, Tibaldo L, Tibolla O, Tinivella M, Troja E, Uchiyama Y, Usher TL, Vandenbroucke J, Vasileiou V, Vianello G, Vitale V, Waite AP, Werner M, Winer BL, Wood KS, Wood M, Yamazaki R, Yang Z, Zimmer S. Detection of the Characteristic Pion-Decay Signature in Supernova Remnants. Science 2013; 339:807-11. [DOI: 10.1126/science.1231160] [Citation(s) in RCA: 508] [Impact Index Per Article: 46.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
189
|
Pletsch HJ, Guillemot L, Fehrmann H, Allen B, Kramer M, Aulbert C, Ackermann M, Ajello M, de Angelis A, Atwood WB, Baldini L, Ballet J, Barbiellini G, Bastieri D, Bechtol K, Bellazzini R, Borgland AW, Bottacini E, Brandt TJ, Bregeon J, Brigida M, Bruel P, Buehler R, Buson S, Caliandro GA, Cameron RA, Caraveo PA, Casandjian JM, Cecchi C, Çelik Ö, Charles E, Chaves RCG, Cheung CC, Chiang J, Ciprini S, Claus R, Cohen-Tanugi J, Conrad J, Cutini S, D’Ammando F, Dermer CD, Digel SW, Drell PS, Drlica-Wagner A, Dubois R, Dumora D, Favuzzi C, Ferrara EC, Franckowiak A, Fukazawa Y, Fusco P, Gargano F, Gehrels N, Germani S, Giglietto N, Giordano F, Giroletti M, Godfrey G, Grenier IA, Grondin MH, Grove JE, Guiriec S, Hadasch D, Hanabata Y, Harding AK, den Hartog PR, Hayashida M, Hays E, Hill AB, Hou X, Hughes RE, Jóhannesson G, Jackson MS, Jogler T, Johnson AS, Johnson WN, Kataoka J, Kerr M, Knödlseder J, Kuss M, Lande J, Larsson S, Latronico L, Lemoine-Goumard M, Longo F, Loparco F, Lovellette MN, Lubrano P, Massaro F, Mayer M, Mazziotta MN, McEnery JE, Mehault J, Michelson PF, Mitthumsiri W, Mizuno T, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Nakamori T, Nemmen R, Nuss E, Ohno M, Ohsugi T, Omodei N, Orienti M, Orlando E, de Palma F, Paneque D, Perkins JS, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Ray PS, Razzano M, Reimer A, Reimer O, Reposeur T, Ritz S, Romani RW, Romoli C, Sanchez DA, Parkinson PMS, Schulz A, Sgrò C, do Couto e Silva E, Siskind EJ, Smith DA, Spandre G, Spinelli P, Suson DJ, Takahashi H, Tanaka T, Thayer JB, Thayer JG, Thompson DJ, Tibaldo L, Tinivella M, Troja E, Usher TL, Vandenbroucke J, Vasileiou V, Vianello G, Vitale V, Waite AP, Winer BL, Wood KS, Wood M, Yang Z, Zimmer S. Binary Millisecond Pulsar Discovery via Gamma-Ray Pulsations. Science 2012; 338:1314-7. [PMID: 23112297 DOI: 10.1126/science.1229054] [Citation(s) in RCA: 84] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
190
|
Ackermann M, Ajello M, Allafort A, Schady P, Baldini L, Ballet J, Barbiellini G, Bastieri D, Bellazzini R, Blandford RD, Bloom ED, Borgland AW, Bottacini E, Bouvier A, Bregeon J, Brigida M, Bruel P, Buehler R, Buson S, Caliandro GA, Cameron RA, Caraveo PA, Cavazzuti E, Cecchi C, Charles E, Chaves RCG, Chekhtman A, Cheung CC, Chiang J, Chiaro G, Ciprini S, Claus R, Cohen-Tanugi J, Conrad J, Cutini S, D’Ammando F, de Palma F, Dermer CD, Digel SW, do Couto e Silva E, Domínguez A, Drell PS, Drlica-Wagner A, Favuzzi C, Fegan SJ, Focke WB, Franckowiak A, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Gehrels N, Germani S, Giglietto N, Giordano F, Giroletti M, Glanzman T, Godfrey G, Grenier IA, Grove JE, Guiriec S, Gustafsson M, Hadasch D, Hayashida M, Hays E, Jackson MS, Jogler T, Kataoka J, Knödlseder J, Kuss M, Lande J, Larsson S, Latronico L, Longo F, Loparco F, Lovellette MN, Lubrano P, Mazziotta MN, McEnery JE, Mehault J, Michelson PF, Mizuno T, Monte C, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Tramacere A, Nuss E, Greiner J, Ohno M, Ohsugi T, Omodei N, Orienti M, Orlando E, Ormes JF, Paneque D, Perkins JS, Pesce-Rollins M, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Razzano M, Razzaque S, Reimer A, Reimer O, Reyes LC, Ritz S, Rau A, Romoli C, Roth M, Sánchez-Conde M, Sanchez DA, Scargle JD, Sgrò C, Siskind EJ, Spandre G, Spinelli P, Stawarz Ł, Suson DJ, Takahashi H, Tanaka T, Thayer JG, Thompson DJ, Tibaldo L, Tinivella M, Torres DF, Tosti G, Troja E, Usher TL, Vandenbroucke J, Vasileiou V, Vianello G, Vitale V, Waite AP, Winer BL, Wood KS, Wood M. The Imprint of the Extragalactic Background Light in the Gamma-Ray Spectra of Blazars. Science 2012; 338:1190-2. [DOI: 10.1126/science.1227160] [Citation(s) in RCA: 184] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
191
|
Falzarano R, Viggiani V, Michienzi S, Colaprisca B, Longo F, Frati L, Anastasi E. CLEIA CA125 evidences: good analytical performance avoiding “Hook effect”. Tumour Biol 2012; 34:387-93. [DOI: 10.1007/s13277-012-0561-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2012] [Accepted: 10/12/2012] [Indexed: 01/26/2023] Open
|
192
|
Longo F, Perri F, Aversa C, Pavone E, Caponigro F, Ionna F. Electrochemotherapy, a novel integrated approach to the locoregional treatment of head and neck cancer. Eur J Surg Oncol 2012. [DOI: 10.1016/j.ejso.2012.07.097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
193
|
Caroli M, Mele RM, Tomaselli MA, Cammisa M, Longo F, Attolini E. Complementary feeding patterns in Europe with a special focus on Italy. Nutr Metab Cardiovasc Dis 2012; 22:813-818. [PMID: 22898449 DOI: 10.1016/j.numecd.2012.07.007] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/08/2012] [Revised: 07/11/2012] [Accepted: 07/21/2012] [Indexed: 12/26/2022]
Abstract
Early nutrition is considered to be crucial for development of persistent obesity in later life. The aim of this paper is to present an overview of complementary feeding patterns across European countries. Most European infants introduce solid foods earlier than 6 completed months of age as recommended by WHO. The commonest risk factors for early introduction of solid foods have been shown to be smoking mothers of young age, low SES and no breastfeeding. The foods most frequently introduced as first solids are fruit and cereals followed by other foods that vary depending on the country of residence and the infants' type of feeding. Insufficient updated information has been made available in Europe in terms of infants' nutrient intake during complementary feeding, as well as on the potential acute metabolic effects of complementary feeding. Websites, e-forums and blogs on complementary feeding are widely spread in the web. The recipes and daily menus published in food industry websites are often nutritionally incorrect. Baby led-weaning (BLW) is based on the principle that babies, upon being started on complementary foods, should be allowed to eat whatever food they want (regular family foods included) in its normal shape. No nutrient intake and metabolic data are nevertheless available about BLW. The current scenario in terms of our understanding of complementary feeding in Europe opens several new research avenues. Not using and not improving our current knowledge of nutrition to improve children's health represents an infringement of children's rights.
Collapse
|
194
|
Grande E, Castellano D, García-Carbonero R, Teulé A, Durán I, Fuster J, Sevilla I, Escudero P, Sastre J, Casanovas O, Ortega L, Earl J, Díez J, de Velasco G, Longo F, Navarro A, Pachón V, Carrato A, Salazar R, Capdevila J. Pazonet: A Phase II Trial of Pazopanib as a Sequencing Treatment in Progressive Metastatic Neuroendocrine Tumors (NETS) Patients (PTS), On Behalf of The Spanish Task Force for Nets (GETNE). Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)33727-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
195
|
Longo F, Mansueto G, Lapadula V, Stumbo L, Del Bene G, Adua D, De Filippis L, Bonizzoni E, Quadrini S. Combination of aprepitant, palonosetron and dexamethasone as antiemetic prophylaxis in lung cancer patients receiving multiple cycles of cisplatin-based chemotherapy. Int J Clin Pract 2012; 66:753-757. [PMID: 22805267 PMCID: PMC3437500 DOI: 10.1111/j.1742-1241.2012.02969.x] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Introduction: With repeated courses of chemotherapy, chemotherapy-induced nausea and vomiting (CINV) becomes progressively more difficult to control. The aim of this study was to evaluate whether the antiemetic efficacy of the triple combination aprepitant, palonosetron and dexamethasone could be sustained for up to six cycles of highly emetogenic chemotherapy (HEC) (cisplatin ≥ 50 mg/m(2) ). Methods: Chemotherapy-naive patients receiving cisplatin-based HEC, were treated with palonosetron 0.25 mg/i.v., dexamethasone 20 mg/i.v. and aprepitant 125 mg/p.o. 1 h before chemotherapy. Aprepitant 80 mg/p.o. and dexamethasone 4 mg/p.o. were administered on days 2-3. The primary endpoint was complete response (CR, no vomiting and no use of rescue medication), over 5 days following HEC in up to six cycles. Secondary endpoints were emesis-free and nausea-free rates. Safety was also evaluated. Results: One hundred and fifty six lung cancer patients were included in the study; the median age was 64 years and 76.9% were men. The minimum cisplatin dosage was 75 mg/m(2) , and in most patients was combined with another drug (87.4%). CR ranged from 74.4% (first cycle) to 82% (sixth cycle). More than 90% and 60% of patients were emesis-free and nausea-free during all chemotherapy cycles. The most commonly reported side effects were constipation and headache. Conclusions: The triple combination of aprepitant, palonosetron and dexamethasone enhanced not only the antiemetic protection during the first cycle, but its efficacy was also sustained for up to six cycles of cisplatin-based HEC in lung cancer patients.
Collapse
|
196
|
Rodriguez de Antona C, Grande Pulido E, Leandro-Garcia L, Barriuso J, Capdevila J, Jimenez P, Castelo B, Castellano DE, Longo F, Garcia-Donas J. Evaluation of CYP3A5, VEGF-a, and VEGFR2 polymorphisms as markers of sunitinib toxicity. J Clin Oncol 2012. [DOI: 10.1200/jco.2012.30.15_suppl.10546] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
10546 Background: Sunitinib (Sun) is a multitargeted tyrosine-kinase inhibitor approved for the treatment of renal cell carcinoma (RCC), GIST and pancreatic neuroendocrine tumors (pNETs). It is known that a polymorphism in Sun metabolizing gene CYP3A5, was associated with an increased risk of dose reductions due to toxicity (tox). Additionally, polymorphisms in VEGF-A and VEGFR2 were suggested to increase the risk of hypertension (HT) during treatment (García-Donas, et al. Lancet Oncol 2011). These data have not been validated so far. We aim to assess the value of these polymorphisms as markers of tox using a wide range of solid tumors treated with Sun. Methods: In this non-interventional and retrospective study, DNA was collected from 28 patients with different pathologies (16 pNETs, 5 medullary thyroid carcinomas, 2 NETs of the lung, 2 undifferentiated follicular carcinomas, 1 undifferentiated papillar carcinoma, 1 GIST, and 1 carcinoid of the rectum) treated with Sun in a daily practice setting. Genotyping for CYP3A5*1 allele (rs776746), VEGF-A -2578C>A (rs699947) and VEGFR2 Q472H (rs1870377) was performed. Associations between the genotypes and Sun dose reductions and HT were performed using univariable analyses. Results: In agreement with previous reports, we found that VEGF-A rs699947 conferred a statistically significant increased risk of developing HT during treatment (HR=9.8, 95%CI=1.2-82.0, P=0.034). CYP3A5*1 high metabolizing allele showed a trend towards the increase in the risk of Sun dose reductions due to tox (HR=2.4, 95%CI=0.8-6.8, P=0.11) with a median time to dose reduction of 7.0 months for wild type homozgygous patients and 4.6 months for heterozygous patients. A trend was also found on the relation between VEGF-A rs699947 A/A patients (HR=3.8, 95%CI=0.8-16.8, P=0.080) and dose reduction risk. No significant associations were found for VEGFR2 rs1870377. Conclusions: The present study suggests that VEGF-A rs699947 is a risk factor for Sun HT and has a role in other tox leading to dose reductions. Similarly, CYP3A5*1 shows a trend towards an increased risk of Sun dose reductions. If confirmed, these markers could be used to identify a subset of patients with an increased risk of Sun toxicity.
Collapse
|
197
|
Agbor G, Tarkang P, Fogha J, Biyiti L, Tamze V, Messi H, Tsabang N, Longo F, Tchinda A, Dongmo B, Donfagsite N, Mbing J, Joseph K, Ngide R, Simo D. Acute and Subacute Toxicity Studies of Aqueous Extract of Morinda lucida Stem Bark. ACTA ACUST UNITED AC 2012. [DOI: 10.3923/jpt.2012.158.165] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
198
|
Ackermann M, Ajello M, Allafort A, Atwood WB, Baldini L, Barbiellini G, Bastieri D, Bechtol K, Bellazzini R, Berenji B, Blandford RD, Bloom ED, Bonamente E, Borgland AW, Bouvier A, Bregeon J, Brigida M, Bruel P, Buehler R, Buson S, Caliandro GA, Cameron RA, Caraveo PA, Casandjian JM, Cecchi C, Charles E, Chekhtman A, Cheung CC, Chiang J, Ciprini S, Claus R, Cohen-Tanugi J, Conrad J, Cutini S, de Angelis A, de Palma F, Dermer CD, Digel SW, do Couto E Silva E, Drell PS, Drlica-Wagner A, Favuzzi C, Fegan SJ, Ferrara EC, Focke WB, Fortin P, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Germani S, Giglietto N, Giommi P, Giordano F, Giroletti M, Glanzman T, Godfrey G, Grenier IA, Grove JE, Guiriec S, Gustafsson M, Hadasch D, Harding AK, Hayashida M, Hughes RE, Jóhannesson G, Johnson AS, Kamae T, Katagiri H, Kataoka J, Knödlseder J, Kuss M, Lande J, Latronico L, Lemoine-Goumard M, Llena Garde M, Longo F, Loparco F, Lovellette MN, Lubrano P, Madejski GM, Mazziotta MN, McEnery JE, Michelson PF, Mitthumsiri W, Mizuno T, Moiseev AA, Monte C, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Nakamori T, Nolan PL, Norris JP, Nuss E, Ohno M, Ohsugi T, Okumura A, Omodei N, Orlando E, Ormes JF, Ozaki M, Paneque D, Parent D, Pesce-Rollins M, Pierbattista M, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Razzano M, Razzaque S, Reimer A, Reimer O, Reposeur T, Ritz S, Romani RW, Roth M, Sadrozinski HFW, Sbarra C, Schalk TL, Sgrò C, Siskind EJ, Spandre G, Spinelli P, Strong AW, Takahashi H, Takahashi T, Tanaka T, Thayer JG, Thayer JB, Tibaldo L, Tinivella M, Torres DF, Tosti G, Troja E, Uchiyama Y, Usher TL, Vandenbroucke J, Vasileiou V, Vianello G, Vitale V, Waite AP, Winer BL, Wood KS, Wood M, Yang Z, Zimmer S. Measurement of separate cosmic-ray electron and positron spectra with the fermi large area telescope. PHYSICAL REVIEW LETTERS 2012; 108:011103. [PMID: 22304252 DOI: 10.1103/physrevlett.108.011103] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/02/2011] [Revised: 11/10/2011] [Indexed: 05/31/2023]
Abstract
We measured separate cosmic-ray electron and positron spectra with the Fermi Large Area Telescope. Because the instrument does not have an onboard magnet, we distinguish the two species by exploiting Earth's shadow, which is offset in opposite directions for opposite charges due to Earth's magnetic field. We estimate and subtract the cosmic-ray proton background using two different methods that produce consistent results. We report the electron-only spectrum, the positron-only spectrum, and the positron fraction between 20 and 200 GeV. We confirm that the fraction rises with energy in the 20-100 GeV range. The three new spectral points between 100 and 200 GeV are consistent with a fraction that is continuing to rise with energy.
Collapse
|
199
|
Ackermann M, Ajello M, Albert A, Atwood WB, Baldini L, Ballet J, Barbiellini G, Bastieri D, Bechtol K, Bellazzini R, Berenji B, Blandford RD, Bloom ED, Bonamente E, Borgland AW, Bregeon J, Brigida M, Bruel P, Buehler R, Burnett TH, Buson S, Caliandro GA, Cameron RA, Cañadas B, Caraveo PA, Casandjian JM, Cecchi C, Charles E, Chekhtman A, Chiang J, Ciprini S, Claus R, Cohen-Tanugi J, Conrad J, Cutini S, de Angelis A, de Palma F, Dermer CD, Digel SW, do Couto e Silva E, Drell PS, Drlica-Wagner A, Falletti L, Favuzzi C, Fegan SJ, Ferrara EC, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Gehrels N, Germani S, Giglietto N, Giordano F, Giroletti M, Glanzman T, Godfrey G, Grenier IA, Guiriec S, Gustafsson M, Hadasch D, Hayashida M, Hays E, Hughes RE, Jeltema TE, Jóhannesson G, Johnson RP, Johnson AS, Kamae T, Katagiri H, Kataoka J, Knödlseder J, Kuss M, Lande J, Latronico L, Lionetto AM, Llena Garde M, Longo F, Loparco F, Lott B, Lovellette MN, Lubrano P, Madejski GM, Mazziotta MN, McEnery JE, Mehault J, Michelson PF, Mitthumsiri W, Mizuno T, Monte C, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Naumann-Godo M, Norris JP, Nuss E, Ohsugi T, Okumura A, Omodei N, Orlando E, Ormes JF, Ozaki M, Paneque D, Parent D, Pesce-Rollins M, Pierbattista M, Piron F, Pivato G, Porter TA, Profumo S, Rainò S, Razzano M, Reimer A, Reimer O, Ritz S, Roth M, Sadrozinski HFW, Sbarra C, Scargle JD, Schalk TL, Sgrò C, Siskind EJ, Spandre G, Spinelli P, Strigari L, Suson DJ, Tajima H, Takahashi H, Tanaka T, Thayer JG, Thayer JB, Thompson DJ, Tibaldo L, Tinivella M, Torres DF, Troja E, Uchiyama Y, Vandenbroucke J, Vasileiou V, Vianello G, Vitale V, Waite AP, Wang P, Winer BL, Wood KS, Wood M, Yang Z, Zimmer S, Kaplinghat M, Martinez GD. Constraining dark matter models from a combined analysis of Milky Way satellites with the Fermi Large Area Telescope. PHYSICAL REVIEW LETTERS 2011; 107:241302. [PMID: 22242987 DOI: 10.1103/physrevlett.107.241302] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/18/2011] [Revised: 10/06/2011] [Indexed: 05/31/2023]
Abstract
Satellite galaxies of the Milky Way are among the most promising targets for dark matter searches in gamma rays. We present a search for dark matter consisting of weakly interacting massive particles, applying a joint likelihood analysis to 10 satellite galaxies with 24 months of data of the Fermi Large Area Telescope. No dark matter signal is detected. Including the uncertainty in the dark matter distribution, robust upper limits are placed on dark matter annihilation cross sections. The 95% confidence level upper limits range from about 10(-26) cm3 s(-1) at 5 GeV to about 5×10(-23) cm3 s(-1) at 1 TeV, depending on the dark matter annihilation final state. For the first time, using gamma rays, we are able to rule out models with the most generic cross section (∼3×10(-26) cm3 s(-1) for a purely s-wave cross section), without assuming additional boost factors.
Collapse
|
200
|
Fainardi V, Iacinti E, Longo F, Tripodi MC, Pisi G. P243 Anxiety and depression in adolescents and adults with cystic fibrosis. Thorax 2011. [DOI: 10.1136/thoraxjnl-2011-201054c.243] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|